The FDA published their final guidance on consultation for combination products

In the US, a combination product is defined as “a product comprised of any combination of a drug, device, and/or biological product.” They are assigned to a lead FDA agency based on the component providing the primary mode of action. This agency will regulate the premarket and postmarket activities. Read more “The FDA published their final guidance on consultation for combination products”